From billion-dollar US verdicts to the first Scottish group action, 2026 is proving to be a watershed year for talcum powder litigation. Here is what claimants need to know.
The Global Picture
The talcum powder scandal continues to expand globally, with the talc scandal affecting hundreds of thousands of individuals worldwide. As of March 2026, over 90,000 talcum powder lawsuits have been filed against Johnson & Johnson, reflecting the unprecedented scale of this public health crisis.
Recent months have brought a succession of landmark verdicts that underscore the strength of claims against the company. December 2025 alone witnessed three major awards: a $1.5 billion verdict in Maryland for a mesothelioma case, $65.5 million in Minnesota for mesothelioma damages, and $40 million in Los Angeles for an ovarian cancer claimant. These sums reflect juries' acceptance that Johnson & Johnson knew of the asbestos risks associated with talcum powder use and failed to warn consumers adequately.
In February 2026, a Philadelphia jury awarded $250,000 to the family of a woman who died from ovarian cancer following decades of using J&J talc-based products. This award is particularly significant as it demonstrates that juries continue to hold the manufacturer accountable even for legacy products. Johnson & Johnson discontinued its talc-based baby powder in 2023, a commercial decision widely interpreted as an implicit admission of the product's dangers.
The Bankruptcy Strategy Rejected
For those following the legal landscape, a crucial development occurred in April 2025 when a bankruptcy judge dismissed Johnson & Johnson's attempt to shield itself from talcum powder claims through Chapter 11 bankruptcy protection. This marked the third time the company's bankruptcy strategy had been struck down, with the presiding judge ruling that J&J had not met the legal threshold to qualify for bankruptcy proceedings.
The rejection of J&J's proposed $8 billion settlement removed a significant impediment to direct litigation. Instead of negotiating within a bankruptcy framework, claimants can now pursue talcum powder compensation through conventional civil court proceedings. The company's aggressive legal strategy has therefore backfired, leaving it exposed to claims in court directly rather than shielded by bankruptcy protections.
However, Johnson & Johnson has not entirely escaped regulatory consequences. In a separate development, the company reached a $700 million settlement with 43 US states over misleading marketing claims regarding the safety of its talc products. This settlement acknowledges the company's failure to communicate known risks to consumers and regulators alike.
The Lancet Retraction: A Game-Changing Discovery
March 2026 brought a bombshell revelation that has significantly strengthened the talcum powder litigation landscape. The Lancet, one of the world's most prestigious medical journals, retracted a 49-year-old unsigned commentary on the safety of cosmetic talc. The commentary, originally published in 1977, had been cited repeatedly by Johnson & Johnson and the talc industry as authoritative scientific evidence supporting talc's safety.
Investigators discovered that the commentary's author, Francis J C Roe, was a paid consultant to Johnson & Johnson at the time of publication. More damaging still, internal records revealed that Roe had provided J&J with an advance copy of the piece and incorporated the company's suggestions before its publication in The Lancet. This extraordinary breach of scientific integrity undermines decades of industry-cited 'evidence' purporting to demonstrate talc safety.
The discovery was made by public health historians David Rosner and Gerald Markowitz, who accessed previously confidential documents obtained during litigation. Their work exemplifies how the talc scandal continues to reveal the systematic nature of Johnson & Johnson's efforts to suppress and manipulate scientific evidence regarding asbestos contamination in its talcum powder products. For claimants, this retraction demolishes a key pillar of the defendant's scientific defence.
The Scottish Group Action: Bringing Claims Home
For residents of Scotland and the wider United Kingdom, 2026 represents a watershed moment with the launch of the first talcum powder group action in the Scottish Court of Session. Jones Whyte Lawyers, a leading Scottish firm, is leading this groundbreaking litigation on behalf of UK claimants.
The representative claimant in this landmark case is Helene Rose, a 67-year-old from Aberdeen, who was diagnosed with Stage 4 ovarian cancer in 2024. Helene's diagnosis came after decades of using J&J talc products, a history consistent with medical evidence linking talcum powder to ovarian cancer. Her case exemplifies the experience of countless individuals who trusted a global pharmaceutical company to provide safe consumer products.
The claimants in the group action allege that Johnson & Johnson possessed knowledge of asbestos contamination in its talc products for decades, yet failed to disclose this information to consumers. Internal company memoranda from the 1960s, discovered during litigation, contain explicit references to tremolite contamination — a form of asbestos — in the company's talc supply chain. Despite this knowledge, J&J continued to market talcum powder as safe for intimate use without appropriate warnings.
The UK group action has already attracted significant interest. Up to 3,000 people across the United Kingdom have filed claims for talcum powder compensation. Importantly, family members can bring claims on behalf of deceased loved ones who used talc products and subsequently developed cancer. This provision ensures that the families of individuals who have already lost their lives to asbestos-related diseases can still access justice.
What Claimants Should Do Now
If you or a family member has used talcum powder and subsequently developed ovarian cancer, mesothelioma, or other asbestos-related diseases, it is essential to act promptly. Limitation periods apply in Scotland and the rest of the United Kingdom, and delays in bringing claims can result in loss of legal rights. Early investigation of your circumstances also helps preserve crucial evidence and testimony.
Jones Whyte Lawyers offers no win, no fee representation to eligible claimants, ensuring that financial barriers do not prevent access to justice. Our experienced team understands the science behind talcum powder litigation and has the expertise to navigate the complexities of group action proceedings. A brief consultation with our specialists can establish whether you have a viable claim and explain your options moving forward.
This article is for general information only and does not constitute legal advice. If you believe you may have a claim, speak to our team about your circumstances.